Skip to content

Insider · CIK 0001937915

Dongfang Liu

officer

Files at NUVB (Nuvation Bio Inc.). First filing May 6, 2025, latest Dec 3, 2025.

Dongfang Liu files SEC Form 4 as officer at NUVB (Nuvation Bio Inc.). Since May 6, 2025, Dongfang Liu has reported 0 open-market buys worth $0 and 5 open-market sells worth $1.7M, the latest filed on Dec 3, 2025.

A track record needs three past buys with six months of prices behind them; Dongfang Liu has 0, so none is measured yet.

The newest scored trade: sold $1.2M of NUVB on Dec 1, 2025, filed Dec 3, 2025, scored 60 (notable). In the last 12 months: 0 buys worth $0 and 4 sells worth $1.6M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $1.7M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NUVB: Nuvation Bio Inc.

NUVBOct 9, 2026 · close 5.00

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
60Notable
NUVBsell 3
Nuvation Bio Inc.
$1.2M
150,000 shares
-89%+375% from low-2% from high
46Moderate
NUVBsell 3
Nuvation Bio Inc.
$155k
20,000 shares
-71%+375% from low0% from high
46Moderate
NUVBsell 3
Nuvation Bio Inc.
$140k
20,000 shares
-53%+322% from low-2% from high
46Moderate
NUVBsell 3
Nuvation Bio Inc.
$148k
30,000 shares
-100%+181% from low-13% from high
7Weak
NUVBsell10b5-1
Nuvation Bio Inc.
$50k
20,000 shares
-63%+48% from low-24% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Dec 1, 2025 NUVB
NUVATION BIO INC.
150,000
0.04% of outstanding
$1.2MDec 1, 2025$443k
Nov 26, 2025 NUVB
NUVATION BIO INC.
10,000
0.00% of outstanding
$80kNov 26, 2025$363k
Nov 25, 2025 NUVB
NUVATION BIO INC.
10,000
0.00% of outstanding
$75kNov 25, 2025$288k
Nov 20, 2025 NUVB
NUVATION BIO INC.
20,000
0.01% of outstanding
$140kNov 20, 2025$148k
Nov 19, 2025 NUVB
NUVATION BIO INC.
15,000
0.00% of outstanding
$77kNov 19, 2025$71k
Nov 17, 2025 NUVB
NUVATION BIO INC.
15,000
0.00% of outstanding
$71kNov 17, 2025none
May 2, 2025 NUVB
NUVATION BIO INC
20,000
0.01% of outstanding
$45kMay 2, 2025none

Transactions

Every row this insider has filed, 22 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 27, 2026NUVB
Nuvation Bio Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+748,130$0.00$0748,130Mar 3, 2026
Dec 1, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Class A Common Stock
+150,000$2.93$440k168,000Dec 3, 2025
Dec 1, 2025NUVB
Nuvation Bio Inc.
SOpen-market sale
Class A Common Stock
-150,000$7.82$1.2M18,000Dec 3, 2025
Dec 1, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Stock Option (Right to Buy)derivative
-150,000$0.00$0165,000Dec 3, 2025
Nov 25, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Class A Common Stock
+10,000$3.61$36k28,000Nov 26, 2025
Nov 25, 2025NUVB
Nuvation Bio Inc.
SOpen-market sale
Class A Common Stock
-10,000$7.50$75k18,000Nov 26, 2025
Nov 26, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Class A Common Stock
+10,000$3.61$36k28,000Nov 26, 2025
Nov 26, 2025NUVB
Nuvation Bio Inc.
SOpen-market sale
Class A Common Stock
-10,000$8.00$80k18,000Nov 26, 2025
Nov 25, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Stock Option (Right to Buy)derivative
-10,000$0.00$0480,000Nov 26, 2025
Nov 26, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Stock Option (Right to Buy)derivative
-10,000$0.00$0470,000Nov 26, 2025
Nov 20, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Class A Common Stock
+20,000$1.87$37k38,000Nov 24, 2025
Nov 20, 2025NUVB
Nuvation Bio Inc.
SOpen-market sale
Class A Common Stock
-20,000$7.00$140k18,000Nov 24, 2025
Nov 20, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Stock Option (Right to Buy)derivative
-20,000$0.00$0450,000Nov 24, 2025
Nov 17, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Class A Common Stock
+15,000$1.87$28k30,000Nov 19, 2025
Nov 17, 2025NUVB
Nuvation Bio Inc.
SOpen-market sale
Class A Common Stock
-15,000$4.77$71k15,000Nov 19, 2025
Nov 19, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Class A Common Stock
+15,000$1.87$28k30,000Nov 19, 2025
Nov 19, 2025NUVB
Nuvation Bio Inc.
SOpen-market sale
Class A Common Stock
-15,000$5.10$77k18,000Nov 19, 2025
Nov 17, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Stock Option (Right to Buy)derivative
-15,000$0.00$0485,000Nov 19, 2025
Nov 19, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Stock Option (Right to Buy)derivative
-15,000$0.00$0470,000Nov 19, 2025
May 2, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Class A Common Stock10b5-1
+20,000$1.94$39k32,000May 6, 2025
May 2, 2025NUVB
Nuvation Bio Inc.
SOpen-market sale
Class A Common Stock10b5-1
-20,000$2.50$50k12,000May 6, 2025
May 2, 2025NUVB
Nuvation Bio Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-20,000$1.94$39k480,000May 6, 2025

Questions about Dongfang Liu

Answered from the filings on this page, as of the latest one.

Is Dongfang Liu buying or selling?

In the last 12 months Dongfang Liu reported 0 open-market buys worth $0 and 4 open-market sells worth $1.6M on SEC Form 4; the latest was sold $1.2M of NUVB on Dec 1, 2025. Grants, option exercises and tax withholding are not counted.

How did Dongfang Liu's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dongfang Liu has 0.

Where does Dongfang Liu file Form 4?

Dongfang Liu has filed Form 4 at NUVB (Nuvation Bio Inc.) as CHIEF MEDICAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dongfang Liu: insider trades and track record | InsiderTell